COVID-19: Anticoagulation withFull Dose or Prophylactic Dose? by Salim Rezaie at REBELT Covid-19

 

COVID-19 and Anticoagulation: Full Dose or Prophylactic Dose?

• Written by Salim Rezaie

“En pacientes no críticos con COVID-19, una estrategia inicial de anticoagulación en dosis terapéutica con heparina aumentó la probabilidad de supervivencia hasta el alta hospitalaria con un uso reducido de soporte de órganos respiratorios o cardiovasculares en comparación con la tromboprofilaxis de atención habitual”.

Articulo en Ingles ENG

 “In noncritically ill patients with COVID-19, an initial strategy of therapeutic-dose anticoagulation with heparin increased the probability of survival to hospital discharge with reduced use of cardiovascular or respiratory organ support as compared with usual-care thromboprophylaxis.”

Read original in the link HERE